Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMT1 | P30419 | 9/20 | 0.45 |
| ▸ | NMT2 | O60551 | 8/20 | 0.45 |
| ▸ | TERT | O14746 | 1/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | GNPAT | O15228 | 1/20 | 0.39 |
| ▸ | TLR2 | O60603 | 2/20 | 0.38 |
| ▸ | GSR | P00390 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30887359 | 1.00 | NMT1 (0.45) | NMT1NMT2TERTFOLH1GNPAT | |
| SCHEMBL29757022 | 0.95 | TERT (0.47) | NMT1NMT2TERTFOLH1GNPAT | |
| SCHEMBL29816775 | 0.93 | NMT1 (0.47) | NMT1NMT2TERTTLR2GSR | |
| SCHEMBL31279969 | 0.93 | NMT1 (0.47) | NMT1NMT2TERTTLR2GSR | |
| SCHEMBL29367996 | 0.92 | NMT1 (0.47) | NMT1NMT2FOLH1GNPATTLR2 | |
| SCHEMBL30616032 | 0.92 | TERT (0.44) | TERTFOLH1GNPATGSRPTGS1 | |
| SCHEMBL29915516 | 0.90 | NMT1 (0.45) | NMT1NMT2FOLH1GNPATTLR2 | |
| SCHEMBL30675546 | 0.90 | TERT (0.43) | NMT1NMT2TERTFOLH1GSR | |
| SCHEMBL30930138 | 0.89 | NMT1 (0.50) | NMT1NMT2 | |
| SCHEMBL5052423 | 0.89 | NMT1 (0.46) | NMT1NMT2TERTFOLH1TLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118005710-A | Method for controlling double-protein coupling proportion based on cyclopeptide and application | 南昌大学 | 2024-05-10 | — | — | CN | disclosed |